The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
出版年份 2016 全文链接
标题
The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-12
出版商
Informa Healthcare
发表日期
2016-03-01
DOI
10.1517/14740338.2016.1160054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study
- (2015) Corinna Weber-Schoendorfer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody
- (2015) J. D. Isaacs et al. JOURNAL OF INTERNAL MEDICINE
- Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol
- (2015) M. E. B. Clowse et al. JOURNAL OF RHEUMATOLOGY
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Jasvinder A Singh et al. LANCET
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. Arthritis & Rheumatology
- The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials
- (2014) Tzeyu L. Michaud et al. AMERICAN JOURNAL OF MEDICINE
- FRI0162 Investigation into the binding affinity of certolizumab pegol to fcrn and functional consequences for fcrn-mediated transcytosis: comparison to infliximab, adalimumab and etanercept
- (2014) T. Baker et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2014) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
- (2014) Pauline Raaschou et al. ANNALS OF THE RHEUMATIC DISEASES
- Morphea associated with the use of adalimumab: a case report and review of the literature
- (2014) Julio Ramírez et al. Modern Rheumatology
- Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies
- (2014) Alejandro Souto et al. RHEUMATOLOGY
- Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0
- (2014) Tatiana Cobo-Ibáñez et al. RHEUMATOLOGY INTERNATIONAL
- Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis
- (2014) J. R. Curtis et al. ARTHRITIS CARE & RESEARCH
- Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden
- (2014) K. Hellgren et al. Arthritis & Rheumatology
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey
- (2013) Raphaèle Seror et al. RHEUMATOLOGY
- Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases
- (2013) Mª Victoria Hernández et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register
- (2012) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
- (2012) Sotirios Tsiodras et al. MAYO CLINIC PROCEEDINGS
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
- (2011) S. M. M. Verstappen et al. ANNALS OF THE RHEUMATIC DISEASES
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
- (2011) K. Au et al. ANNALS OF THE RHEUMATIC DISEASES
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
- (2011) X. Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab-associated Pulmonary Cryptococcosis
- (2011) Takashi Iwata et al. Annals of Thoracic and Cardiovascular Surgery
- Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents
- (2011) Pauline Raaschou et al. ARTHRITIS AND RHEUMATISM
- TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- (2011) Victoria L. Williams et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry
- (2011) María José Pérez-Sola et al. MEDICINA CLINICA
- Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry
- (2011) Noemí Busquets et al. RHEUMATOLOGY
- Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?
- (2011) M. V. Hernandez et al. RHEUMATOLOGY
- Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
- (2011) María Cruz Fernández-Espartero et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0
- (2010) L. Carmona et al. RHEUMATOLOGY
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
- (2010) T. Ding et al. RHEUMATOLOGY
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries
- (2010) Jeffrey R. Curtis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
- (2010) Angelique N. Collamer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
- (2010) Loreto Carmona et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Bullous Pemphigoid during Long-Term TNF-α Blocker Therapy
- (2009) Matteo Bordignon et al. DERMATOLOGY
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
- (2009) J. D. CARTER et al. JOURNAL OF RHEUMATOLOGY
- Lichen planus–like eruptions: An emerging side effect of tumor necrosis factor-α antagonists
- (2009) Adam Asarch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population
- (2007) Lydia Abásolo et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started